Clinical studies with mithramycin.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000633:toxicity; D001943:Breast Neoplasms / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002822:Choriocarcinoma / Q000188:drug therapy; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D009365:Neoplasm Regression, Spontaneous; D009369:Neoplasms / Q000188:drug therapy*; D011041:Poisoning / Q000209:etiology; D011247:Pregnancy; D013724:Teratoma / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy; D014839:Vomiting / Q000139:chemically induced
D000970:Antineoplastic Agents